DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click HERE
to register or log in.
CD133-Targeted Natural Killer Cell Therapy for Aggressive Prostate Cancer
Approved For Public Release